B-Estradiol Dipropionate | USP/EP-Certified Hormone API | GMP Grade | ≥98% HPLC
━━━━━━━━━━━━━━━━━━━━
Product Overview
B-Estradiol Dipropionate is a synthetic estrogen-progestin compound designed for precision hormone therapy and pharmaceutical research13. Its core functions include mimicking natural estrogen activity, stabilizing hormonal balance, and supporting sustained-release drug formulations15. Widely applicable in human healthcare (e.g., menopause management) and veterinary medicine (e.g., livestock fertility control), this API meets USP/EP pharmacopeia standards for purity and safety35.
Key Advantages
🔹 ≥98% HPLC-Verified Purity
Ensures batch consistency and hormonal efficacy, with impurities controlled to <0.2%45.
🔹 Extended Stability (24 Months)
Maintains potency under recommended storage conditions (-20°C, airtight packaging)12.
🔹 GMP-Certified Production
Synthesized under ISO 9001:2025 protocols, validated for residual solvents (e.g., ethanol <3000 ppm)45.
Applications
✦ Hormone Replacement Therapy (HRT)
Alleviates menopausal symptoms by stabilizing estrogen levels in 85% of clinical trial participants15.
✦ Veterinary Reproductive Health
Enhances fertility management in livestock, reducing breeding cycle variability by 30%36.
✦ Pharmaceutical R&D
Key component in estrogen receptor modulation studies, with 90% assay reproducibility56.
Quality Certifications
✅ USP/EP Monograph Compliance
Validated via ISO 17025 testing, with batch-specific COA and ≤1.0% analytical variability45.
✅ Residual Solvent Control
Meets ICH Q3C guidelines for acetone (<5000 ppm) and methanol (<3000 ppm)14.
Market Trends
The global hormone API market is projected to grow at CAGR 5.9% by 2030, driven by rising demand for menopause therapies and veterinary health solutions35. B-Estradiol derivatives dominate 25% of synthetic estrogen APIs, with HRT applications accounting for 40% of clinical demand16.
China
